Belmont, MA, United States of America

Jun Ma

USPTO Granted Patents = 30 

 

Average Co-Inventor Count = 7.5

ph-index = 8

Forward Citations = 193(Granted Patents)


Location History:

  • Belmont, CA (US) (2015)
  • Belmont, MA (US) (2014 - 2023)
  • Wayland, MA (US) (2022 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
30 patents (USPTO):

Title: **Innovative Contributions of Jun Ma in Pharmaceutical Research**

Introduction

Jun Ma, based in Belmont, MA, is an accomplished inventor with an impressive portfolio of 29 patents. His work primarily focuses on the development of innovative pharmaceutical compounds aimed at addressing various diseases, particularly those associated with apoptosis signal regulation and viral infections.

Latest Patents

Among his latest patented inventions, Jun has developed inhibitors of Apoptosis signal-regulating kinase 1 (ASK-1). The compounds disclosed in his patents show promising potential in treating autoimmune disorders, neurodegenerative disorders, inflammatory diseases, chronic kidney disease, and cardiovascular disease. Specifically, these inventions offer methods for treating ASK-1 related diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcohol steatohepatitis (NASH).

Additionally, Jun has also pioneered spiropyrrolidine derived antiviral agents. These compounds demonstrate the ability to inhibit coronavirus replication, contributing to the development of therapeutic strategies for preventing and treating coronavirus infections. The pharmaceutical compositions related to these inventions showcase a commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Jun Ma has worked at leading companies such as Enanta Pharmaceuticals and Elmore Patent Law Group, P.C. These roles have allowed him to leverage his expertise in patent law and pharmaceutical research, further enhancing his ability to innovate and protect his inventions.

Collaborations

Jun has collaborated with esteemed colleagues, including Yat Sun Or and Guoqiang Wang. These collaborations underscore the importance of teamwork and the sharing of knowledge in the pursuit of groundbreaking medical advancements.

Conclusion

Jun Ma's contributions to pharmaceutical research through his numerous patents highlight his role as a significant innovator in the field. His work on ASK-1 inhibitors and antiviral agents not only showcases his dedication to addressing serious health issues but also sets a foundation for future advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…